Literature DB >> 33671638

Disabling VEGF-Response of Purkinje Cells by Downregulation of KDR via miRNA-204-5p.

Julian Gehmeyr1, Abdelouahid Maghnouj2, Jonas Tjaden1, Matthias Vorgerd3, Stephan Hahn2, Veronika Matschke1, Verena Theis1, Carsten Theiss1.   

Abstract

The vascular endothelial growth factor (VEGF) is well known for its wide-ranging functions, not only in the vascular system, but also in the central (CNS) and peripheral nervous system (PNS). To study the role of VEGF in neuronal protection, growth and maturation processes have recently attracted much interest. These effects are mainly mediated by VEGF receptor 2 (VEGFR-2). Current studies have shown the age-dependent expression of VEGFR-2 in Purkinje cells (PC), promoting dendritogenesis in neonatal, but not in mature stages. We hypothesize that microRNAs (miRNA/miR) might be involved in the regulation of VEGFR-2 expression during the development of PC. In preliminary studies, we performed a miRNA profiling and identified miR204-5p as a potential regulator of VEGFR-2 expression. In the recent study, organotypic slice cultures of rat cerebella (postnatal day (p) 1 and 9) were cultivated and VEGFR-2 expression in PC was verified via immunohistochemistry. Additionally, PC at age p9 and p30 were isolated from cryosections by laser microdissection (LMD) to analyse VEGFR-2 expression by quantitative RT-PCR. To investigate the influence of miR204-5p on VEGFR-2 levels in PC, synthetic constructs including short hairpin (sh)-miR204-5p cassettes (miRNA-mimics), were microinjected into PC. The effects were analysed by confocal laser scanning microscopy (CLSM) and morphometric analysis. For the first time, we could show that miR204-5p has a negative effect on VEGF sensitivity in juvenile PC, resulting in a significant decrease of dendritic growth compared to untreated juvenile PC. In mature PC, the overexpression of miR204-5p leads to a shrinkage of dendrites despite VEGF treatment. The results of this study illustrate, for the first time, which miR204-5p expression has the potential to play a key role in cerebellar development by inhibiting VEGFR-2 expression in PC.

Entities:  

Keywords:  KDR; Purkinje cells; VEGF; VEGFR-2; cerebellum; dendritic growth; miRNA-204-5p; microinjection; organotypic slice cultures

Mesh:

Substances:

Year:  2021        PMID: 33671638      PMCID: PMC7926311          DOI: 10.3390/ijms22042173

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  78 in total

1.  Impact of vegf on astrocytes: analysis of gap junctional intercellular communication, proliferation, and motility.

Authors:  Ricarda Wuestefeld; Jingchen Chen; Karl Meller; Beate Brand-Saberi; Carsten Theiss
Journal:  Glia       Date:  2012-03-19       Impact factor: 7.452

2.  Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.

Authors:  Peter Baumgarten; Anna-Eva Blank; Kea Franz; Elke Hattingen; Maika Dunst; Pia Zeiner; Katharina Hoffmann; Oliver Bähr; Lisa Mäder; Benjamin Goeppert; Marcia Machein; Volker Seifert; Joachim P Steinbach; Karl H Plate; Patrick N Harter; Michel Mittelbronn
Journal:  Neuro Oncol       Date:  2015-11-30       Impact factor: 12.300

Review 3.  Role of vascular endothelial growth factor in adult hippocampal neurogenesis: implications for the pathophysiology and treatment of depression.

Authors:  Neil M Fournier; Ronald S Duman
Journal:  Behav Brain Res       Date:  2011-04-22       Impact factor: 3.332

4.  miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay.

Authors:  Sergej Djuranovic; Ali Nahvi; Rachel Green
Journal:  Science       Date:  2012-04-13       Impact factor: 47.728

5.  Vascular endothelial growth factor is involved in mediating increased de novo hippocampal neurogenesis in response to traumatic brain injury.

Authors:  Cheol Lee; Denes V Agoston
Journal:  J Neurotrauma       Date:  2010-03       Impact factor: 5.269

6.  Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only.

Authors:  E Brogi; T Wu; A Namiki; J M Isner
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

Review 7.  Intravitreal anti-VEGF drug delivery systems for age-related macular degeneration.

Authors:  Andrea Luaces-Rodríguez; Cristina Mondelo-García; Irene Zarra-Ferro; Miguel González-Barcia; Pablo Aguiar; Anxo Fernández-Ferreiro; Francisco J Otero-Espinar
Journal:  Int J Pharm       Date:  2019-10-26       Impact factor: 5.875

Review 8.  Advances in the treatment of diabetic retinopathy.

Authors:  Rishi P Singh; Michael J Elman; Simran K Singh; Anne E Fung; Ivaylo Stoilov
Journal:  J Diabetes Complications       Date:  2019-08-15       Impact factor: 2.852

9.  A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands.

Authors:  Lindsay E Clegg; Feilim Mac Gabhann
Journal:  PLoS Comput Biol       Date:  2017-03-20       Impact factor: 4.475

Review 10.  Insights into the Mechanisms Involved in Protective Effects of VEGF-B in Dopaminergic Neurons.

Authors:  Beatrice Caballero; Scott J Sherman; Torsten Falk
Journal:  Parkinsons Dis       Date:  2017-04-03
View more
  1 in total

1.  Neuroprotective Metabolites of Hericium erinaceus Promote Neuro-Healthy Aging.

Authors:  Elisa Roda; Erica Cecilia Priori; Daniela Ratto; Fabrizio De Luca; Carmine Di Iorio; Paola Angelone; Carlo Alessandro Locatelli; Anthea Desiderio; Lorenzo Goppa; Elena Savino; Maria Grazia Bottone; Paola Rossi
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.